Purchases and Sales Made in Q4 2021 in Anebulo Pharmaceuticals, Inc. (ANEB)
This table provides information about the institutional ownership of Anebulo Pharmaceuticals, Inc. (ANEB) during Q4 2021. The information is specifically focused on institutions that hold shares of Anebulo Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2022
Q4 2021
|
22 Nw, LP
Seattle, WA |
BUY
|
- |
19.1K+ 0.57% |
$112K - $140K
|
3.36M
$5.45M
|
|
|
Feb 10, 2022
Q4 2021
|
Black Rock Inc.
New York, NY |
BUY
|
- |
200+ 2.63% |
$1.17K - $1.46K
|
7.81K
$12.7K
|
|
|
Feb 14, 2022
Q4 2021
|
Morgan Stanley
New York, NY |
BUY
|
- |
2New |
$11.7 - $14.6
|
2
$3.24
|
|
|
Feb 07, 2022
Q4 2021
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-39Closed |
$228 - $285
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Ubs Group Ag
|
SELL
|
- |
-268- 31.6% |
$1.57K - $1.96K
|
580
$940
|
|
|
Feb 14, 2022
Q4 2021
|
Mangrove Partners
New York, NY |
SELL
|
- |
-9.49K- 2.28% |
$55.4K - $69.3K
|
407K
$659K
|